CINECA IRIS Institutional Research Information System
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Torino.
AperTO è l'archivio istituzionale Open Access destinato a raccogliere, rendere visibile e conservare la produzione scientifica dell'Università degli Studi di Torino.
ItalianoSCAGLIOTTI, Giorgio Vittorio
Pubblicazioni
Risultati 1 - 20 di 393 (tempo di esecuzione: 0.001 secondi).
| Titolo | Data di pubblicazione | Autore(i) | |
|---|---|---|---|
| 1 | 141PD: Whole body and intracranial efficacy of ceritinib in patients (pts) with crizotinib (CRZ) pretreated, ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) and baseline brain metastases (BM): Results from ASCEND-1 and ASCEND-2 trials | 2016 | Felip, E; Crinò, L; Kim, D-W; Spigel, D R; Nishio, M; Mok, T; Scagliotti, G; Cesic, D; Sutradhar, S; Shaw, A T |
| 2 | A randomized phase II study comparing induction or consolidation chemotherapy with cisplatin-docetaxel, plus radical concurrent chemoradiotherapy with cisplatin-docetaxel, in patients with unresectable locally advanced non-small-cell lung cancer. | 2011 | Senan S; Cardenal F; Vansteenkiste J; Stigt J; Akyol F; De Neve W; Bakker J; Dupont JM; Scagliotti GV; Ricardi U; van Meerbeeck JP. |
| 3 | Abiraterone and prednisone therapy may cause severe hypoglycemia when administered to prostate cancer patients with type 2 diabetes receiving glucose-lowering agents | 2019 | Tucci M.; Roca E.; Ferrari L.; Pia A.; Dalla Volta A.; Bedussi F.; Buttigliero C.; Vittorio Scagliotti G.; Sigala S.; Berruti A. |
| 4 | The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data | 2019 | Navani, Neal*; Fisher, David J.; Tierney, Jayne F.; Stephens, Richard J.; Burdett, Sarah; Rydzewska, Larysa H.M.; Auperin, Anne; Le Chevalier, Thierry; Le Pechoux, Cécile; Pignon, Jean-Pierre; Arriagada, Rodrigo; Johnson, David H.; van Meerbeeck, Jan; Parmar, Mahesh K.B.; Stewart, Lesley A.; Bunn, Paul A.; Dautzenberg, Bertrand; Gilligan, David; Groen, Harry; Knuuttila, Aija; Vallieres, Eric; Rosell, Rafael; Roth, Jack; Scagliotti, Giorgio; Tsuboi, Masahiro; Waller, David; Westeel, Virginie; Wu, Yi-Long; Yang, Xue-Ning |
| 5 | Adapting clinical practice guidelines to a regional oncology network: the Piedmont experience | 2007 | GELORMINO E; PAGANO E; APPIANO S; CECCARELLI M; CIUFFREDA L; COMANDONE A; FARINA E; MERLETTI F; MUSSA A; PENNA A; PONTI A; RACITI I; SCAGLIOTTI GV; SEGNAN N; SENORE C; SISMONDI P; VINEIS P; BERTETTO O; CICCONE G |
| 6 | Addition of docetaxel to androgen deprivation therapy for patients with hormone-sensitive metastatic prostate cancer: A systematic review and meta-analysis | 2016 | Tucci, Marcello; Bertaglia, Valentina; Vignani, Francesca; Buttigliero, Consuelo; Fiori, Cristian; Porpiglia, Francesco; Scagliotti, Giorgio Vittorio; Di Maio, Massimo |
| 7 | Addressing the unmet need in lung cancer: The potential of immuno-oncology | 2015 | Scagliotti, G.V; Bironzo, P.; Vansteenkiste, J.F. |
| 8 | Adjuvant and Neoadjuvant approaches for non small cell lung cancer | 2005 | Scagliotti GV; Everett E. V. |
| 9 | Adjuvant chemotherapy after complete resection for early stage NSCLC | 2003 | SCAGLIOTTI G ;NOVELLO S |
| 10 | Adjuvant chemotherapy for resected early-stage non-small cell lung cancer | 2015 | Burdett, S; Pignon, Jp; Tierney, J; Tribodet, H; Stewart, L; Le Pechoux, C; Auperin, A; Le Chevalier, T; Stephens, Rj; Arriagada, R; Higgins, Jpt; Johnson, Dh; Van Meerbeeck, J; Parmar, Mkb; Souhami, Rl; Bergman, B; Douillard, Jy; Dunant, A; Endo, C; Girling, D; Kato, H; Keller, Sm; Kimura, H; Knuuttila, A; Kodama, K; Komaki, R; Kris, Mg; Lad, T; Mineo, T; Piantadosi, S; Rosell, R; Scagliotti, G; Seymour, Lk; Shepherd, Fa; Sylvester, R; Tada, H; Tanaka, F; Torri, V; Waller, D; Liang, Y |
| 11 | Adjuvant chemotherapy in completely resected Non-small cel lung cancer. | 2005 | GIORGIO V. SCAGLIOTTI; S. NOVELLO; AND VALTER TORRI |
| 12 | Adjuvant chemotherapy in completely resected Non-Small Cell Lung Cancer, cap 32 | 2005 | GIORGIO V. SCAGLIOTTI; S. NOVELLO; AND VALTER TORRI |
| 13 | Adjuvant therapy for surgically resected NSCLC: update from ASCO 2004. Selected presentations from the 5th international Lung Cancer , Kauai, Hi July 2004 | 2004 | Scagliotti GV; Novello S. |
| 14 | Adjuvant therapy in completely resected non-small-cell lung cancer | 2003 | Scagliotti, G.V., Novello, S |
| 15 | Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial. | 2012 | Ramlau R; Gorbunova V; Ciuleanu TE; Novello S; Ozguroglu M; Goksel T; Baldotto C; Bennouna J; Shepherd FA; Le-Guennec S; Rey A; Miller V; Thatcher N; Scagliotti G. |
| 16 | Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain | 2015 | Sperlinga, R.; Campagna, S.; Berruti, A.; Laciura, P.; Ginosa, I.; Paoletti, S.; Giuliano, P.L.; Tucci, M.; Rosato, R.; Scagliotti, G.V.; Saini, Andrea |
| 17 | ALK Rearrangement Testing by FISH Analysis in Non-Small-Cell Lung Cancer Patients: Results of the First Italian External Quality Assurance Scheme. | 2014 | Marchetti A;Barberis M;Papotti M;Rossi G;Franco R;Malatesta S;Buttitta F;Ardizzoni A;Crinò L;Gridelli C;Taddei GL;Clemente C;Scagliotti G;Normanno N;Pinto C |
| 18 | ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. | 2012 | Scagliotti G; Stahel RA; Rosell R; Thatcher N; Soria JC. |
| 19 | ALTERED MRNAS EXPRESSION OF GENES INVOLVED IN CELLULAR IRON HOMEOSTASIS IN LUNG NON SMALL CELLS CARCINOMA | 2012 | Lo Iacono M; Roetto A; Monica V; Boero M; Vavala T; Saviozzi S; Bracco E; Novello S; Papotti M; Scagliotti GV |
| 20 | Angiogenesis in stage in Non-Small-Cell Lung cancer (NSCLC) expression of Human protesa - activated receptors (PARS) | 2004 | GHIO P; SELVAGGI G; NOVELLO S; CAPPIA S; PAPOTTI M; GIORIO S; CAGGESE D; BORASIO P; LAUSI P; SCAGLIOTTI GV |
Dettaglio
SCAGLIOTTI, Giorgio Vittorio
ONCOLOGIA
Copyright © 2020